Примери за използване на Peripheral neuropathies на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The warning about peripheral neuropathies should be included/amended as follows.
Muscle pain may be part of many neuromuscular disorders including myopathies, peripheral neuropathies and lower motor neuron diseases.
Peripheral neuropathies, including the Guillain- Barré syndrome and nerve entrapment syndromes.
A new or current warning statement on peripheral neuropathies should include at least the following information.
Peripheral neuropathies(excluding motor neuropathy), Dizziness, Tremor, Dysgeusia, Headache.
This syndrome may be caused by anemia,renal failure or peripheral neuropathies, although an exact cause is unknown.
Neutropenia and peripheral neuropathies occurring during treatment with atezolizumab and nabpaclitaxel may be reversible with interruptions of atezolizumab and/or nab-paclitaxel.
It can assess disorders of the autonomic nervous system, peripheral neuropathies, and some other types of pain disorders.
Important weight losses and peripheral neuropathies which can potentially not recover or lead to sequelae, are still reported with almitrine despite risk minimisation measures in place for several years.
Circulatory problems like hardening of the arteries, atherilsclerosis, athrosclerosis,Angina, Peripheral Neuropathies, High blood pressure and blocked arteries.
Both motor and sensory peripheral neuropathies have been reported, overall in 9% of the patients.
Even if occurrence of peripheral neuropathy in COPD patients with associated conditions could be consideredas a confounding factor, the occurrence of cases with positive rechallenge with almitrine during the post-marketing experience is strongly in favour of a causal relationship between almitrine and peripheral neuropathies.
Spontaneous reports of peripheral neuropathies persist even after the introduction of sequential administration scheme.
Tremor, headache seizures, disturbances in consciousness,paraesthesias and dysaesthesias, peripheral neuropathies, dizziness, writing impaired, nervous system disorders 8.
The PRAC noted that most cases of peripheral neuropathies reported from September 2003 to December 2012 were not recovered or recovered with sequelae.
Gastrointestinal and abdominal pain, asthenic conditions,upper respiratory tract infections and peripheral neuropathies were 12%-15% lower in the subcutaneous group than in the intravenous group.
Peripheral neuropathies(including the preferred terms neuropathy peripheral, peripheral motor neuropathy, peripheral sensorimotor neuropathy, peripheral sensory neuropathy, polyneuropathy, and polyneuropathy in malignant disease) were reported in 29% of the patients and were mostly(98%) mild to moderate(CTCAE grade≤ 2).
Further, it has been demonstrated that peripheral neuropathies can persist beyond 6 months of paclitaxel discontinuation.
Paresthesia, Paralysis(including Bell's palsy,facial paralysis), Peripheral neuropathies(polyradiculoneuritis, Guillain Barre Syndrome), Neuritis(including optical neuritis), Myelitis(including transverse Myelitis), Encephalitis, Demyelinating disease of the central nervous system, Exacerbation of multiple sclerosis, Multiple sclerosis, Seizure, Headache, Dizziness, Syncope.
Nervous system disorders, seizures,disturbances in consciousness, peripheral neuropathies, dizziness, paraesthesias and dysaesthesias, writing impaired uncommon.
Nervous system disorders Very rare(< 1/ 10,000) Paresthesia,paralysis(Bell's palsy), peripheral neuropathies(polyradiculoneuritis, facial paralysis), neuritis(including Guillain Barre Syndrome, optical neuritis, myelitis including transverse myelitis), encephalitis, demyelinating disease of the central nervous system, exacerbation of multiple sclerosis, multiple sclerosis, seizure, headache, dizziness, syncope.
During the course of the pivotal study, 46% of the peripheral neuropathies as well as the majority(78%) of the associated reactions resolved.
In published clinical studies with continuous administration1234567, peripheral neuropathies and weight loss were encountered when the study duration was longer than 3 months, indicating that the duration of continuous exposure have played a role in their development.
During the period September2003 to December 2012, 20 cases of peripheral neuropathies were reported, suggesting that the risk minimisation measures are not able to prevent the occurrence of these reactions.
Nervous system disorders headache, tremor nervous system disorders seizures,disturbances in consciousness, peripheral neuropathies, dizziness, paraesthesias and dysaesthesias, writing impaired encephalopathy, central nervous system haemorrhages and cerebrovascular accidents, coma, speech and language ab-normalities, paralysis and paresis, amnesia hypertonia myasthenia.
Peripheral neuropathy, neuropathy. .
These are: peripheral neuropathy, peripheral arterial disease and infection.
Vinflunine did not induce peripheral neuropathy in animals.
Peripheral neuropathy, neuropathy, hypoaesthesia, paraesthesia.
Peripheral neuropathy.